A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
MYD88 L265P Mutation Detection by PCR, Quantitative
MessageNon-interfaced to ARUP
Test Code
MYD88ARUP
Alias/See Also
ARUP 2009318
Lymphoplasmacytic lymphoma
Waldenstrom macroglobulinemia
Lymphoplasmacytic lymphoma
Waldenstrom macroglobulinemia
CPT Codes
81305 (ZB2MU)
Instructions
See link below for specimen details, methodology, setup schedule and reference ranges.
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Whole Blood, Bone Marrow or Extracted DNA: Plasma, serum, or DNA extracted by a non-CLIA lab. Specimens collected in anticoagulants other than EDTA or sodium heparin. Clotted or grossly hemolyzed specimens.
FFPE Tumor Tissue: Specimens fixed/processed in alternative fixatives, heavy metal fixatives (B-4 or B-5), or tissue sections on slides. Decalcified specimens.
FFPE Tumor Tissue: Specimens fixed/processed in alternative fixatives, heavy metal fixatives (B-4 or B-5), or tissue sections on slides. Decalcified specimens.
FDA Status
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Additional Information
MYD88ARUP